BWX Technologies, Inc. — Q1 2023 Form 10-Q Summary
Business context and reporting period
BWXT operates in Government Operations and Commercial Operations, providing naval nuclear reactors, nuclear components, government nuclear-site services, commercial nuclear equipment and medical radioisotopes. The filing covers the three months ended March 31, 2023, compared with the three months ended March 31, 2022. The financial statements are unaudited and presented under U.S. GAAP.
Key financial metrics
| Metric | Q1 2023 | Q1 2022 | Change |
|---|---|---|---|
| Revenue | $568.4 million | $530.7 million | +7.1% |
| Operating income | $87.8 million | $71.6 million | +22.7% |
| Operating margin | 15.5% | 13.5% | +2.0 percentage points |
| Net income attributable to BWXT | $61.1 million | $59.0 million | +3.5% |
| Diluted EPS | $0.67 | $0.64 | +4.7% |
| Net cash used in operating activities | $13.0 million | $5.4 million | Use increased |
| Capital expenditures | $29.8 million | $52.4 million | Down $22.6 million |
Government Operations revenue increased 6.5% to $459.9 million, with operating income rising 25.4% to $90.6 million and margin improving to 19.7% from 16.7%. Commercial Operations revenue increased 9.0% to $108.9 million, but operating income declined 61.8% to $1.5 million and margin fell to 1.4% from 4.0%.
Net income was affected by a substantial change in other income and expense: Q1 2023 included $8.2 million of net other expense versus $5.9 million of net other income in Q1 2022. Interest expense increased to $10.8 million from $7.1 million, while Q1 2022 benefited from $12.8 million of other net income, including foreign-exchange-related items. The effective tax rate was 23.4%, compared with 23.7%.
Balance sheet, debt and liquidity
- Cash and cash equivalents were $42.1 million; total cash, including restricted cash, was $47.5 million at March 31, 2023.
- Working capital was $502.9 million, up from $403.8 million at December 31, 2022, primarily because of higher contracts in progress and retainages and lower current liabilities.
- Total debt was approximately $1.37 billion, including $1.36 billion of long-term debt and $6.3 million of current maturities. Debt increased from approximately $1.29 billion at year-end 2022.
- The company had $330.0 million of Revolving Credit Facility borrowings, $2.6 million of revolving letters of credit and $417.4 million of remaining revolving borrowing and letter-of-credit capacity. Term Loan borrowings were $248.4 million.
- The weighted-average interest rate on Credit Facility borrowings was 6.17%. BWXT also had $400 million of 4.125% senior notes due 2028 and $400 million of 4.125% senior notes due 2029.
- BWXT was in compliance with its credit facility and senior note covenants at March 31, 2023. Management stated that available liquidity, operating cash flow and capital-market access were sufficient for expected requirements over the next 12 months and beyond.
Material changes versus the prior comparable period
- Revenue increased $37.6 million, driven by higher Government Operations volume and advanced-technology engineering work, as well as higher Commercial Operations volume.
- Operating income increased $16.3 million, primarily from Government Operations, including improved performance at several U.S. Government facilities and favorable product mix.
- Commercial Operations profitability declined because of project and product mix and $1.2 million of additional restructuring-related costs.
- Net operating cash flow weakened by $7.6 million, largely because of project cash-flow timing, higher retainages and contracts in progress.
- Investing cash outflows decreased by $36.1 million, primarily because of lower capital expenditures and no comparable investment in equity-method investees.
- Financing provided $49.3 million, including $127.0 million of borrowings and $48.6 million of debt repayments. No share repurchases were made under the announced program, although $6.9 million of shares were withheld for employee taxes.
- Quarterly dividends declared increased to $0.23 per share from $0.22 per share.
Guidance, outlook, risks and unusual items
- Remaining performance obligations, or backlog, were $3.774 billion at March 31, 2023, down from $4.144 billion at December 31, 2022. Approximately 65% is expected to be recognized by the end of 2024. Backlog included $96.3 million of unfunded U.S. Government backlog and excluded approximately $200 million of unexercised options subject to annual appropriations.
- Backlog and Government Operations results remain subject to U.S. Government budgets, appropriations, contract modifications and cancellations.
- Management expects significant initial capital contributions over the next 12 months for a joint venture associated with a DOE contract awarded in April 2023; the filing does not provide a clear dollar estimate.
- Net unfavorable contract-estimate changes reduced revenue and operating income by approximately $7.8 million in Q1 2023, compared with $5.2 million in Q1 2022. Cost overruns on fixed-price contracts, labor productivity, material prices and completion-date guarantees could materially affect results.
- Commercial Operations is exposed to maintenance-outage timing, cyclical capital spending, nuclear-fuel demand and refurbishment activity.
- BWXT had approximately $113.6 million of outstanding surety bonds and $34.9 million of bilateral letters of credit supporting regulatory and contractual obligations. Management believed capacity was adequate for existing requirements over the next 12 months, but noted that issuers and sureties may demand collateral or terminate facilities.
- Underfunded pension and postretirement obligations totaled approximately $78.0 million. Expected contributions for the remainder of 2023 were approximately $5.5 million, subject to additional contributions based on funding and tax considerations.
- The company reported no material contingencies during the period and no material changes to its previously disclosed risk factors or internal control over financial reporting.
Important facts investors should verify
- Whether Government Operations growth and the improved 19.7% segment margin are sustainable, particularly as contract mix and facility performance change.
- The causes and duration of Commercial Operations’ margin compression and restructuring costs.
- Conversion of the $3.774 billion backlog into revenue and cash, including the effect of unfunded backlog and appropriations.
- Working-capital requirements and whether retainages and contracts in progress continue to pressure operating cash flow.
- Debt reduction plans, interest-rate exposure and compliance with the 4.00-to-1.00 maximum net leverage and 3.00-to-1.00 minimum interest-coverage covenants.
- The scale and timing of capital contributions for the DOE joint venture awarded in April 2023.
- Potential cost growth, estimate revisions and performance obligations on fixed-price contracts.